Livestock production is of great importance for the economy of most South American countries, a region that accounts for 23.0% of the world cattle population (Food Agriculture Organization -FAO, 2017). Not surprisingly, the embryo industry is historically very active in this region, particularly in Argentina and Brazil. The field of bovine embryo transfer underwent a remarkable change in the past two decades in Brazil, mainly due to in vitro embryo production (IVEP). Total embryo production increased dramatically, along with constant changes in the main features of the embryo industry -from market niches to mass production, from beef to the dairy sector, from zebu to European breeds. Recently, IVEP has also emerged in other South American countries. This review summarizes and describes factors driving the changes in the Brazilian embryo industry and discusses some of the impacts upon other embryo-related technologies.
Introduction
The embryo industry has been very active in South America in the past 20 years, with several countries reporting data on embryo production and transfers to the International Embryo Technology Society (IETS), mainly in cattle and horses. Until 2008, however, the methodology used by the data retrieval committee pooled data from each region and presented results as totals. Therefore, before 2009 detailed records are only available from Brazil and Argentina. The IETS reports published afterwards show data for the production of bovine embryos, either in vivo or in vitro, from the following countries: Argentina, Brazil, Chile, Colombia, Ecuador, Peru, and Uruguay, as well as reports on the export of embryos to Ecuador and Paraguay (Stroud, 2011 (Stroud, , 2012 and Perry, 2013 and Perry, , 2014 and Perry, , 2015 and Perry, , 2016 . Thus, there are reports of cattle embryo transfer (ET) activity in the past eight years in most of the South American countries. These countries encompass 92.8% of the cattle herd within this region (FAO, 2017) , so available data provides a good picture of the ET activity in South America.
Argentina and Brazil have both the largest cattle herds (51,646,544 and 212,366,132 heads in 2014, respectively) and the most active embryo industries in South America. They were consistently ranked among the top countries doing ET in the past 20 years. Brazilian embryo industry has undergone a dramatic increase between 2002 and 2012 (+642.7, or about 55% per year), primarily due to the commercial use of in vitro embryo production (IVEP; Viana et al., 2017) . On the other hand, the use of IVEP in Argentina increased in the past five years and only in 2016, transfers of in vitro produced (IVP) embryos reached a 5-digit number (20,234), overtaking in vivo derived (IVD) embryos (15, 586) .
The earlier adoption of in vitro embryo technologies was the main reason for the divergence in embryo production trends between the two countries after 2001 (Fig. 1) . Taking into account the ratio between embryo production and cattle population in 2014, Brazil ranks 11th in the world, whereas Argentina is the 22nd (Viana et al., 2017) . Nevertheless, in both countries the use of IVEP was associated with an increase in total embryo production in cattle.
Argentina and Brazil have also a very active horse embryo industry, reporting an average of 7,400 and 12,840 embryos collected per year, respectively, from 2006 to 2015. Note that there are some missing data for both countries in a couple of the years mentioned, which limits the characterization of the scenario and trends for this species. There are also occasional reports on ET activity in sheep, goats, and alpacas in South America (Perry, 2013 (Perry, , 2014 (Perry, , 2015 (Perry, , 2016 . Gathering data from species other than cattle and horse has been a challenge over the years and the numbers reported undoubtedly underestimate the use of embryo technologies in small ruminants in this region.
In summary, bovine is the most important species for the South American embryo industry and Brazil is the main player for the development of embryo technologies in this region, considering both the total numbers of embryos and launching novel trends, such as the earlier use of IVEP in large scale. Thus, many of the aspects of ET development discussed in this paper are supported by data in cattle and from Brazil. 
The effect of IVEP in South America embryo industry
Perhaps the most noticeable features of the embryo industry in South America were the changes introduced by the adoption of in vitro technologies. The history of IVEP in Brazil goes back to the early 1990`s, when different research groups started to focus on these technologies. The first calf produced in vitro in Brazil was born in 1993, followed by the birth of the first zebu IVP calf, and then the first calf from a cryopreserved IVP embryo (Rubin, 2005) . However, there are no official reports about the commercial use of IVEP in Brazil until 1997, and less than 100 IVP embryos were transferred per year in 1998 and 1999.
Meanwhile, IVEP was already intensively used in other continents. By the middle of the 1980's, several commercial IVEP laboratories were developed in North America and Europe (Faber et al., 2003) and, by 1997, IVP embryos corresponded to 12.6% of all transfers in Europe and 17.5% in Asia (Thibier, 1998) . Europe was the region leading the use of IVEP, with 59.9% (18,380 of 30,569) of all IVP embryos transferred worldwide in 1997. In this scenario, although Brazil and Argentina usually ranked within the top five countries in the transfer of IVD embryos outside Europe and North America, there was still no clear sights on the significant shift in the embryo industry scenario that was about to come.
The whole picture started to change in 2000, when Brazil first reported the production of more than 10,000 IVP embryos. A consistent growth in commercial IVP boosted South American numbers. Only two years later, in 2002, this region already accounted for 58.4% (48,670 of 83,329) of the IVP embryos transferred worldwide (Thibier, 2003) . In spite of the usual fluctuations in numbers among different regions through the years, since 2006 Brazil is responsible for >50% of the IVP embryos worldwide. In fact, the adoption of IVEP was responsible for the remarkable participation of Brazil in the world total embryo production after 2002 (Fig. 2) . The growth in the use of IVEP in other regions, as currently observed in North America (Fig. 3) , will probably increase world total numbers and, consequently, balance the participation of the main players in the world's embryo industry.
It is important to highlight that IVEP changed not only the magnitude of ET numbers, but also the modus operandi of the embryo industry in Brazil and, together with its emergence in other countries, is likely to cause similar effects elsewhere. Since 2005, IVP replaced superovulation as the technique of choice for bovine embryo production (Viana et al., 2012) and the rapid expansion of commercial IVP laboratories pushed traditional ET companies to embrace the new technology. The embryo production process, previously centered in the veterinarian practitioner, now resembles a complex and multi-step production line, which requires technicians with a number of distinct skills.
With the use of transvaginal ultrasound-guided follicle aspiration (OPU), the availability of cumulusoocyte complexes was no longer a bottleneck because multiple donors can be collected to achieve the number of oocytes predicted to be necessary to generate the required number of embryos. Conversely, the low cryotolerance of IVP embryos have made the availability of suitable recipients a critical factor within Viana et al. Embryo-related ET programs. The increasing efficiency of embryo production in vitro (Watanabe et al., 2017) , as well as the use of IVEP in large scale (Pontes, 2010 (Pontes, , 2011 affected the costs of IVP embryo-related services, the profit margins, and consequently the business model adopted by commercial companies. 
The factors driving the embryo market in Brazil
The reasons behind changes in the Brazilian embryo industry in the past two decades are complex and frequently misunderstood. Embryo technologies have been intensively studied over the past decades and a number of comprehensive review articles have addressed many practical aspects of IVEP. It has some advantages, when compared to embryo production in vivo by superovulation, such as the shorter interval between embryo production cycles, the possibility of collecting pre-pubertal or pregnant donors, and of generating contemporaneous calves from the same dam using multiple sires, among other benefits (Galli et al., 2001; Hansen and Block, 2004; Thibier, 2005) .
The efficiency of in vitro maturation, fertilization, and embryo culture, however, is generally low (Lonergan and Fair, 2008) . Moreover, artificial in vitro culture conditions can alter epigenetic marks (Urrego et al., 2014) and affect embryonic gene expression (Lonergan et al., 2006) . Altogether, these factors affect the quality and cryotolerance of IVP embryos (Lonergan et al., 2006) and have also been associated with higher pregnancy losses, errors in fetal programming (Chen et al., 2015; Siqueira et al., 2017) , and abnormal offspring phenotype, a condition frequently referred to as the large offspring syndrome (Farin et al., 2006) . Besides, IVEP requires a much more complex and expensive laboratory infrastructure, with direct impact upon production costs. In this scenario, it was reasonable to consider IVEP as an expensive and uneconomic technology (Gordon, 2003) , with a perspective of use as a complement to multiple ovulation and embryo transfer (MOET) programs, particularly for donors that do not respond to superovulation or presenting abnormalities in the reproductive tract (Faber et al., 2003) . So, what made IVEP so successful in South America?
Despite the known flaws of the technology, commercial IVEP in Brazil was initially supported by the high demand and high prices of selected sires and dams, especially high-genetic merit oocyte donors of zebu breeds (Viana et al., 2012) . The focus back then was to produce superior animals for breeding programs, as occurred in other parts of the world (Galli et al., 2003; Smeaton et al., 2003) . Nevertheless, particularities of the Brazilian embryo industry at that time generated a virtuous circle for IVEP. The high number and quality of cumulus-oocyte complexes (COC) retrieved from zebu breeds (Pontes et al., 2011) , for example, resulted in a high embryo yield per session. This led to a reduction in pregnancy costs, which in turn stimulated an increase in the use of IVEP, and the scale effect to promoted further declines in the price of embryos and services. Thus, the technology progressively became economically viable for a greater number of breeds and farmers. Finally, development of IVEP promoted the parallel growth of a chain of suppliers of veterinary services, hormones, IVP media, equipment, disposables, recipients, etc; contributing to a cost reduction and improvements in logistics.
Three phases of IVEP development in Brazil have been previously described (Viana et al., 2012) . The initial period described in the paragraph above was followed by two distinct growth cycles (Fig. 4) . First, beef breeds, mainly Nelore, accounted for 82.7% of all embryos transferred in Brazil in 2005 (Viana et al., 2012) . This growth cycle was probably associated with a repressed demand for young sires, if one takes into account that in 2008 only approximately 6% of beef cows and heifers were artificially inseminated in Brazil (Baruselli et al., 2012) . The second cycle was characterized by the use of IVEP in dairy breeds, particularly in Girolando (Gir x Holstein crossbreds). The availability of commercial X-sorted semen after 2005 was a turning point for the development of IVEP in dairy breeds. Previously, depending on the breed, sire, and culture conditions, the use of conventional semen for IVF resulted consistently in a higher proportion of male births (Alomar et al., 2008; Camargo et al., 2010; Rubessa et al., 2011) , which did not meet the expectations of dairy farmers. Therefore, the lack of X-sorted semen in the early 2000's may explain why the IVEP growth cycle occurred later in dairy, if compared to the early growth in beef breeds.
The emergence of IVEP in dairy breeds highlighted two major changes in the Brazilian embryo industry features. Firstly, IVEP became an alternative for large scale production of replacement heifers, particularly in crossbred herds (Pontes et al., 2010) , instead of a reproductive tool restricted to elite animal breeding programs and high-value donors. This represents an important shift in the perception of the potential (and therefore the impact) of IVEP outside Europe and North America -until recently, this technology was referred to as of little application in cattle breeding, particularly in developing countries (Rodriguez-Martinez, 2012) . Secondly, the use of Bos taurus and crossbreds for IVEP increased dramatically and, in 2013, overcame the production of embryos in pure breed Bos indicus (Viana et al., 2017) .
More than a simple change in market demand, this shift towards Bos taurus suggests that the technical and operational improvements in IVEP made the technique economically interesting even for breeds with lower oocyte yields. Thus, the high number of COC recovered from breeds such as Nelore that might have supported the early emergence of IVEP in Brazil, was no longer a bottleneck for the adoption of in vitro technologies. This hypothesis is supported by the late development of IVEP in Argentina (Fig. 1) , in which Bos taurus breeds are predominant. The increase in embryo production in dairy and Bos taurus breeds also turned the South American embryo industry more similar to the North American, with a relative balance between dairy and beef ( A parallel development convergent with the new demands of the embryo industry was related to protocols for synchronization of ovulation. These protocols were initially developed for timed artificial insemination (TAI) and currently account for most of AI breedings in Brazil (Baruselli et al., 2012; Sartori et al., 2016) . Protocols for timed embryo transfer (TET) were soon adapted for the preparation of embryo recipients Bó et al., 2011) , and are currently being used in commercial ET programs, with results similar to those obtained using TAI (Pellegrino et al., 2016) . The main advantage for the use of TET protocols is to increase the synchrony between the embryo developmental stage and the recipient's uterus, required for achievement of higher pregnancy rates after ET, besides eliminating the well-known problems of estrous detection efficiency (Senger, 1994) . Protocols for TET were particularly useful due to the preference for the transfer of fresh IVP embryos (77.9% in South America in 2016; Perry, 2017) and the need to optimize the use of recipients in dairy herds, usually smaller than beef operations. This also have certainly contributed to the long-lasting cycle of growth of IVEP in dairy breeds. (Vieira et al., 2014; Silva et al., 2017) .
A number of research groups are currently developing embryo biotechnologies in Universities and research Institutes throughout South American countries and some of these technologies, such as micromanipulation for embryo sexing or genotyping are beginning to be used commercially. Only recently, however, this kind of data started to be collected by IETS (Perry, 2017) and there are still no comprehensive data for analysis. Bovine clones have been produced in Brazil and in Argentina (Meirelles et al., 2010; Cánepa et al., 2014) . Table 2 shows the number of birth records from zebu breeds in Brazil that were derived from SCNT. Despite the low efficiency of embryo reconstruction and very high rates of embryonic loss, abortion, and stillbirths (Chavatte-Palmer et al., 2012) , SCNT numbers have increased in the past few years, demonstrating that the demand for the use of the technology has overcome the technical difficulties and, consequently, the high production cost. As expected, most clones were from Nelore (62.5%) and Gir (26.9%), which are the most important beef and dairy zebu breeds in Brazil, respectively. Nonetheless, it is remarkable that the majority of calves (142 of 160, 89.0%) were females and this was true for all breeds. This is probably evidence of a greater interest in cloning high-value oocyte donors, though clones of important sires have also been produced. 
Conclusions
Over the past few decades, embryo industry in South America has been very active, particularly in cattle, with some particular differences among countries. The adoption of IVEP in this region directed significant changes in total embryo production, as well as in the main features of the cattle embryo industry. This phenomenon was first observed in Brazil, which allowed this country to become a reference in the use of in vitro embryo technologies and supported the development of other embryo-related technologies. Finally, as IVEP is currently in open expansion in other countries, similar effects are likely to be observed in those regions as well.
